BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32928923)

  • 1. Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors.
    Jung HJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2020 Nov; 30(11):1780-1783. PubMed ID: 32928923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
    Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
    Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline epithelial ovarian tumors: a single center experience.
    Numanoglu C; Ulker V; Kuru O; Akbayir O; Sakinci M; Akyol A
    Eur J Gynaecol Oncol; 2014; 35(6):692-5. PubMed ID: 25556277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
    Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
    Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
    Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
    Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic restaging of borderline ovarian tumors.
    Daraï E; Tulpin L; Prugnolle H; Cortez A; Dubernard G
    Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging procedures in patients with mucinous borderline tumors of the ovary do not reveal peritoneal or omental disease.
    De Decker K; Speth S; Ter Brugge HG; Bart J; Massuger LFAG; Kleppe M; Kooreman LFS; Kruitwagen RFPM; Kruse AJ
    Gynecol Oncol; 2017 Feb; 144(2):285-289. PubMed ID: 27889017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study.
    Guvenal T; Dursun P; Hasdemir PS; Hanhan M; Guven S; Yetimalar H; Goksedef BP; Sakarya DK; Doruk A; Terek MC; Saatli B; Guzin K; Corakci A; Deger E; Celik H; Cetin A; Ozsaran A; Ozbakkaloglu A; Kolusari A; Celik C; Keles R; Sagir FG; Dilek S; Uslu T; Dikmen Y; Altundag O; Ayhan A
    Gynecol Oncol; 2013 Dec; 131(3):546-50. PubMed ID: 24016409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases.
    Bostwick DG; Tazelaar HD; Ballon SC; Hendrickson MR; Kempson RL
    Cancer; 1986 Nov; 58(9):2052-65. PubMed ID: 3756820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
    Anfinan N; Sait K; Ghatage P; Nation J; Chu P
    Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
    Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.